Meet The Team

Find out more

Management Team

Janet Downie

Chief Executive Officer

Janet Downie is the CEO of RoslinCT.  Janet has over 25 years’ experience in biologics manufacturing and testing and was previously the COO for Roslin Cells Ltd and part of the original team that established the business. She then went on to set up the contract manufacturing division prior to the establishment of RoslinCT. 

Janet has held various senior roles in operations and quality within Inveresk Research, PPL Therapeutics and Charles River Laboratories.  She has always had a passion for business growth through delivering a quality service and a focus on patient safety. Janet holds a BSc (Hons) in Biological Sciences and is a member of UK Task force for ATMP Manufacturing and the BIA Cell Therapy and Manufacturing Committees.

Janet has a love for animals and has a house full of dogs and cats. She would have more if she could. She also enjoys spending time in the countryside and has recently developed a passion for fishing.

Kevin Bruce

Chief Operating Officer

Kevin joined the team in 2019 as our Chief Operating Officer.

He has more than 20 years working within a regulated scientific environment for small biotech, large CROs and SMEs. With a background in quality control and engineering, Kevin has held positions in Operations, Quality, R&D and commercial development. He was previously responsible for Roslin Cells’ collaborative projects for the development, GMP translation and manufacture of cell therapies for both pre-clinical and clinical development. More recently, as COO at Censo Biotechnologies, he established the operational capability for the European Bank for Induced Pluripotent Stem Cells and was responsible for Censo’s stem cell generation, genome editing and assay development operations for drug discovery.

Kevin loves playing football and golf, hill walking and spending time with his family and friends!

David McNab

Chief Financial Officer

David is responsible for all Finance related areas within the business and joined RoslinCT in 2017 to support the company’s strategic growth plans.

David has over 30 years Financial and Commercial experience in a number of businesses within the Service Industries and was part of the team who grew and subsequently sold a global leading contract manufacturing and development organisation focused on liquid and semi-solid capsule products to a major US Pharmaceutical company.

David enjoys Golf and World Travel and spending time with his grandchildren.

Dr Lindsay Fraser

Cell Therapy Development Manager

Lindsay joined the team in 2012 to establish the induced pluripotent stem cell (iPSC) core facility. She now has responsibility for leading the cell therapy research and development projects, and in the translation of research protocols to regulatory compliant GMP manufacturing processes. The development team design and optimise complementary cell characterisation assays to monitor cell health during processing. 

Lindsay finds her role is constantly evolving, in response to novel advances in regenerative medicine. She has a passion for the development and implementation of new technology and in helping cell therapy products reach the clinic.   

She has experience in regenerative medicine, GMP processing and cellular therapy application, working across clinical, academic and commercial sectors including the Scottish National Blood Transfusion Service, Edinburgh University (PhD), Miltenyi Biotec and Biobest Laboratories.

Lindsay loves the great outdoors, festivals and time out with friends and family.

Dr Victoria Robertson

Quality Control Manager

Victoria joined the team in 2018 as Quality Control Manager. She has responsibility for ensuring regulatory compliance for all QC activities. These activities include ensuring the continuing performance of the cleanroom facility at the SCRM and the design, scheduling and implementation of QC testing activities within a GMP environment to support manufacturing projects.

Victoria has over 10 years of cell therapy and GxP quality management gained in the NHS and in commercial settings, having worked to ISO9001, ISO13485 and ISO15189 standards, as well as in HTA, MHRA and FDA regulated environments. She gained a BSc (Hons) in Medical Microbiology and a PhD in cellular immunotherapy both from the University of Edinburgh. Victoria has since then completed a PGCert in Translational Medicine and trained as a Clinical Scientist in histocompatibility and immunogenetics. She has presented her work at both national and international conferences.

Victoria enjoys cooking (and eating!) and spending time with her family!

Inside About Us

Get In Touch

NINE Edinburgh BioQuarter, 9 Little France Road
Edinburgh, United Kingdom, EH16 4UX

+44 (0) 131 658 5180